Benitec Biopharma Inc.BNTCNASDAQ
LOADING
|||
EBITDA Over Time
Trending lower, below historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-41.70M
↓ 188% below average
Average (9y)
$-14.49M
Historical baseline
Range
High:$2.74M
Low:$-41.70M
CAGR
+13.4%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2025 | $-41.70M | -94.8% |
| 2024 | $-21.41M | -11.8% |
| 2023 | $-19.15M | -7.2% |
| 2022 | $-17.85M | -32.7% |
| 2021 | $-13.45M | -70.1% |
| 2020 | $-7.91M | -388.5% |
| 2019 | $2.74M | +131.9% |
| 2018 | $-8.59M | -104.9% |
| 2017 | $-4.19M | +68.8% |
| 2016 | $-13.42M | - |